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Context:  Sulfur  mustard  (SM)  was  used  during  the  Iraq-Iran  war  (1980–1988).  Exposed  veterans  continue
to  suffer  from  its  ocular,  skin,  and  respiratory  complications.
Objective: We  aimed  to evaluate  associations  between  early  (at  the  time  of  acute  exposure)  and  decades
later  skin  manifestations  in  individuals  with  severe  ophthalmologic  complications  secondary  to  sulfur
mustard  exposure.
Materials and methods:  One  hundred  forty-nine  veterans  with  severe  ocular  injuries  were  evaluated  for
acute and  chronic  skin  complications.  Logistic  regression  models  were  used  to  examine  the associations
between  early  and  late  skin  manifestations.
Results:  Late  skin  complaints  were  observed  in  nearly  all survivors  who  had  early  skin  lesions (131  out  of
137; 95.62%).  Seven  out  of 12 patients  (58.33%)  who  did not  have  early  skin  lesions  ultimately  developed
late  skin  complications.  There  was a signiﬁcant  relationship  between  the  presence  of  lesions  at  the time
of  exposure  and developing  late skin  complaints  (two-sided  Fisher’s  exact  test, OR  =  15.59,  p <  0.001).
There  was an  association  between  having  at least  one  early  skin  lesion  and  occurrence  of late  skin  com-
plications.  Survivors  with  blisters  at the  time  of  chemical  exposure  were  more  likely to  complain  of
itching  (95%  CI: 3.63–25.97,  p < 0.001),  burning  (OR  = 11.16;  95%  CI:  2.97–41.89,  p  < 0.001),  pigmentation
changes  (OR =  10.17;  95%  CI: 2.54–40.75,  p =  0.001),  dryness  (OR = 6.71,  95%  CI:  1.22–37.01,  p =  0.03)  or
cherry  angioma  (OR  =  2.59;  95%  CI:1.21–5.55,  p =  0.01)  during  the  late phase.  Using  multivariate  logistic
models,  early  blisters  remained  signiﬁcantly  associated  with  latent  skin  complaints.  Of note,  the genitalia
and great  ﬂexure  areas were  the  most  involved  anatomical  sites  for both  early  and late  skin  lesions  in  SM
exposed  survivors.
Conclusion:  According  to  this  study,  the  presence  of  blisters  at the  time  of exposure  to  SM  is  the most
important  predictor  of developing  dermatologic  complications  decades  later  in  patients  with  severe
tions
d  by ophthalmologic  complica
© 2016  Publishe
. IntroductionChemical warfare agents were ﬁrst widely used in World War
 and were employed again during the Iraq-Iran war (1980–1988).
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About 45,000 victims are still suffering from long-term complica-
tions of SM exposure during the Iran-Iraq War  [12]. Unprotected
victims who  were exposed to either vapor or liquid forms of the
sulfur mustard have been documented as developing deforming
skin blisters in addition to respiratory and ophthalmologic dam-
age. The skin in particularis signiﬁcantly affected by exposure to
sulfur mustard, because of its large surface area and the sensitivity
of basal keratinocytes [20,21,26].
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Demographic characteristics of SM exposed survivors with severe ophthalmologic
complications (n = 149).
Sex No. (%)
Male 148 (99.33%)
Age, years
Mean (SD) 45.84 (8.64)
Median (Range) 43 (22–76)
Time since ﬁrst exposure, years
Mean (SD) 21.9 (1.14)
Median (Range) 22 (16–26)
Age at the time of exposure, years
Mean (SD) 23.93 (8.40)
Median (Range) 21.50 (1–53)
Frequency of chemical gas exposure, no. (%)80 S. Hejazi et al. / Toxicolo
About 80% of the SM that contacts human skin will evaporate
nd only the remaining 20% will penetrate into the underlying tis-
ue. However, once absorbed by the skin, SM cannot be removed
nd within ten minutes bound to the epidermal and dermal tissue,
ostly in the corniﬁed layer. Sulfur mustard damages the cells that
egenerate after injury, such as basal cells in the skin [15].
Sulfur mustard forms carbonium ions and transient complexes
ith large molecules that induce severe electrophilic tissue reac-
ions. SM is also mutagenic and cytotoxic via modiﬁcations in
NA structure. Through these mechanisms, sulfur mustard affects
early every organ system, including the dermatological, ophthal-
ological, respiratory, haematological, gastrointestinal, endocrine,
euro-muscular, and immune systems. The pathophysiology of
ermatological injury has been studied to a limited extent.
istopathological examination of skin biopsies has revealed epi-
ermal atrophy, keratosis, basal membrane hyperpigmentation,
brosis, and melanophages within the dermis [3,4].This is thought
o occur because SM reacts with skin proteins, suppressing laminin
nd integrin and leading to loss of cellular and extracellular
tructure. These skin proteins constitute the attachment protein
omplex responsible for epidermal-dermal adhesion [23]. Sepa-
ation of the epidermal cells causes early phase symptoms like
rythema and blistering [3].
Severe inﬂammation secondary to SM-related tissue damage
lso causes damage to other components of the skin, includ-
ng sweat and sebaceous glands and pigment cells [5]. Despite
nowledge about the acute effects of sulfur mustard injury, there
s incomplete information regarding the cellular and molecular
echanisms responsible for the chronic adverse effects of exposure
1].
Studies about chronic skin effects in chemical-injured veterans
re limited [3,7]. Most victims experience non-lethal but debili-
ating injuries with long-term morbidity. Moreover, there are no
ffective therapeutic options for the delayed toxic effects of SM.
t is thus important to understand how chronic complications and
ubsequent skin cancers can be decreased via close management
nd follow-up of acute effects [20,14,22]. In the present study, we
imed to ﬁnd the spatial and temporal relationships between early
nd late skin lesion in SM-exposed survivors with severe ophthal-
ologic complications.
. Methods
This cross-sectional study was performed to assess the acute
nd chronic skin complications and the relationship between them
n Iranian SM exposed survivors with severe ocular injuries. A
otal of 149 SM-exposed Iranian victims suffering from severe
cular injuries were recruited for the study. Severity of ocular
njuries was veriﬁed by the Medical Commission of Veterans and
artyrs Affairs Foundation (VMAF) of Iran. Written informed con-
ent was obtained from all subjects. Demographic characteristics,
ncluding sex, age, age at the time of exposure, time since ﬁrst
xposure, and frequency of exposure were obtained from patient
edical records. Data on acute and sub-acute skin manifesta-
ions, including erythema, blister, scaling, and pigmentation were
lso collected from patient records. Chronic dermatologic disease
as assessed using patient-reported symptoms and physical exam
ndings observed by an expert dermatologist (cherry angioma,
urning, pigmentation changes, xerosis, photosensitivity, hives,
air loss, and pruritis).
The locations of lesions were classiﬁed based on location: head &
eck, trunk, mucous membranes, ﬂexures, genitalia, extremities, or
eneralized. Univariate and multivariate logistic regression models
ere used to examine whether there were relationships betweenOne exposure 99 (66.44%)
More than one exposure 50 (33.56%)
early and late skin complaints in SM exposed survivors. All statis-
tical analysis was  performed using statistical software SPSS 16.0.
3. Results
The patient characteristics are shown in Table 1. Of the 149 vic-
tims with SM exposure-induced severe ophthalmological injuries,
137 (91.94%) cases had at least one type of skin lesion at the time of
SM exposure. The most common type of cutaneous ﬁndings were
erythema (78.52%), blistering (71.81%), scaling (85.23%), and pig-
mentation (86.58%) (Table 2). The distribution of skin lesions at the
time of exposure is shown in Table 2. Of note, the genitalia and
great ﬂexures are the most commonly involved anatomical sites
(56.41%), followed by the head and neck region (Table 2).
Of the 149 chemical warfare victims, 92.62% had late cutaneous
complaints. The most common skin problems were as follows:
itching (83.89%), burning (72.48%), cherry angioma (71.81%), pig-
mentation changes (61.74%), dryness (38.25%), photosensitivity
(14.76%), hair loss (2.68%), and hives (1.34%). The location distribu-
tion of late skin lesions is shown in Table 3. Burning, pruritis, and
pigmentation changes were most found in the great ﬂexures and
genitalia. The trunk was the most common site for cherry angioma
and the mucous membranes for xerosis.
Late skin complaints were observed nearly in all survivors with
early skin lesions 95.62% (131 out of 137). Seven out of 12 patients
without skin lesions (58.33%) at the time of exposure also devel-
oped late skin complaints. There was a signiﬁcant relationship
between lesions at the time of chemical exposure and develop-
ing late skin complaints (two-sided Fisher’s exact test, OR  = 15.59,
p < 0.001). Univariate logistic regression predicting late skin com-
plaints in chemical warfare victims is illustrated in Tables 4–6 .
Univariate logistic regression indicated that patients with blis-
ters at the time of exposure were 9.71 times more likely to
develop itching complaint later (95% CI: 3.63–25.97, p < 0.001).
Also, patients with early erythema, scaling, and pigmentation
lesions were signiﬁcantly more likely to have pruritis later (Table 4).
The univariate analysis also showed that having latent burning
was associated with having blisters (OR = 9.97, 95% CI: 4.35–22.81,
p < 0.001), erythema (OR = 6.31, 95% CI: 2.71–14.68, p < 0.001), scal-
ing (OR = 3.23; 95% CI:1.27–8.20, p = 0.02) and being 20 years old
or younger (OR = 2.35; 95% CI:1.07–5.17, p = 0.03) at the time of
chemical exposure (Table 4).
Having blister, erythema and being 20 years old or younger at
the time of chemical exposure was signiﬁcantly related to devel-
oping cherry angioma (Table 5).Early cutaneous lesions (blister, scaling, pigmentation and
erythema) were not signiﬁcantly related to developing late photo-
sensitivity (Table 6). The victims with blister and erythema lesions
at the time of chemical exposure were signiﬁcantly at higher risk
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Table  2
Frequency distribution of skin lesions at the time of SM exposure according to the location of lesions.
Erythema No. (%) Blisters No. (%) Scaling No. (%) Pigmentation No. (%)
Total 117 (78.52%) 107 (71.81%) 127 (85.23%) 129 (86.58%)
Location  of Lesions
Head & Neck 21 (17.95%) 21 (19.63%) 21 (16.53%) 20 (15.50%)
Trunk  9 (7.69%) 8 (7.48%) 7 (5.51%) 8 (6.20%)
Extremities 15 (12.82%) 14 (13.08%) 13 (10.24%) 12 (9.30%)
Great  Flexures 66 (56.41%) 57 (53.27%) 48 (37.79%) 45 (34.88%)
Genitalia 66 (56.41%) 58 (54.21%) 49 (38.58%) 46 (35.66%)
Mucous Membranes – – – 1 (0.77%)
Generalized 39 (33.33%) 38 (35.51%) 68 (53.54%) 72 (55.81%)
Table 3
Frequency of distribution of SM late skin complaints according to the location of lesions.
Burning
No. (%)
Pruritis No.
(%)
Cherry
angiomata
No. (%)
Pigmentation
changes
No. (%)
Xerosis
No. (%)
Photo
sensitivity
No. (%)
Hairloss No. (%) Hives No. (%) Bulla No. (%)
Total 108
(72.48)
125
(83.89)
107
(71.81)
92
(61.74)
57
(38.25)
22
(14.76)
4
(2.68)
2
(1.34)
–
Location of lesions
Head & Neck 8
(7.41)
12
(9.60)
1
(0.93)
12
(13.04)
2
(3.51)
22
(100)
3 1 –
Trunk 11
(10.18)
16
(12.80)
96
(89.72)
23
(25.00)
– – – 1 –
Extremities 18
(16.67)
24
(19.20)
17 (15.89) 42
(45.65)
– – – – –
Great Flexures 34
(31.48)
46
(36.80)
1
(0.93)
52
(56.52)
2
(3.51)
– – – –
Genitalia 28
(25.93)
40
(32.00)
1
(0.93)
56
(60.87)
2
(3.51)
– – 1 –
MucousMembranes – – – – 26
(45.61)
– – – –
Generalized 22
(20.37)
26
(20.80)
1
(0.93)
12
(13.04)
25
(43.86)
– 1 – –
Table 4
Univariate logistic regression predicting pruritis and burning in SM exposed survivors.
With risk factor Without risk factor
Prevalence of pruritis
RISK FACTOR N % N % P OR  95% CI
Acute  dermatologic complication
Blistering 100 93.46 25 59.52 <0.001 9.71 (3.63–25.97)
Erythema 106 90.60 19 59.37 <0.001 6.59 (2.58–16.87)
Scaling 112 88.19 13 59.09 0.002 5.17 (1.89–14.14)
Pigmentation 112 86.82 13 65.00 0.02 3.55 (1.24–10.15)
Chemical exposure ≥ 1 time 41 82.00 84 84.85 0.81 0.81 (0.33–2.01)
Age  ≤ 20 at the time of exposure 52 85.24 73 83.00 0.71 1.19 (0.48–2.92)
At  least one type of early skin lesion 120 87.59 5 41.66 0.001 9.88 (2.82–34.67)
Prevalence of burning
RISK FACTOR N % N % P OR  95% CI
Acute  dermatologic complication
Blistering 92 86.00 16 38.09 <0.001 9.97 (4.35–22.81)
Erythema 95 81.20 13 40.62 <0.001 6.31 (2.71–14.68)
Scaling 97 76.40 11 50.00 0.02 3.23 (1.27–8.20)
Pigmentation 97 75.19 11 55.00 0.06 2.48 (0.94–6.52)
Chemical exposure ≥ 1 time 36 72.00 72 72.73 0.92 0.96 (0.45–2.06)
58 
4 
o
3
r
a
p
cAge  ≤ 20 at the time of exposure 50 82.00 
At  least one type of early skin lesion 104 75.91 
f having late pigmentation changes complaint (OR = 8.78, 95% CI:
.88–19.88, p < 0.001 and OR = 6.24, 95% CI: 2.62–14.86, p < 0.001,
espectively). Table 5 shows the results of univariate regression
nalysis in more details.
Blisters remained a signiﬁcant predictor for developing latent
ruritis after adjusting the early skin lesions for each other. Chemi-
al warfare victims with early blister lesions were 8.24 times more65.91 0.03 2.35 (1.07–5.17)
33.33 0.004 6.30 (1.78–22.28)
likely to develop late phase pruritis (OR = 8.24, 95% CI: (1.97–34.50),
p = 0.004), and 6.71 times more likely to have xerosis (OR = 6.71, 95%
CI: 1.22- 37.01, p = 0.03). In addition, multivariate logistic analysis
indicated that patients with early blistering were at higher risk of
developing burning (OR = 11.16; 95% CI: 2.97–41.89, p < 0.001) and
pigmentation changes (OR = 10.17, 95% CI: 2.54–40.75, p = 0.001).
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Table 5
Univariate logistic regression predicting cherry angiomata and pigmentation changes in SM exposed survivors.
With risk factor Without risk factor
Prevalence of cherry angioma
RISK FACTOR N % N % P OR 95% CI
Acute dermatologic complication
Blistering 83 77.57 24 57.14 0.01 2.59 (1.21–5.55)
Erythema 89 76.07 18 56.25 0.03 2.47 (1.09–5.60)
Scaling  95 74.80 12 54.54 0.051 2.47 (0.98–6.27)
Pigmentation 96 74.42 11 55.00 0.07 2.38 (0.91–6.25)
Chemical exposure ≥ 1 time 36 72.00 71 71.71 0.97 1.01 (0.48–2.16)
Age  ≤ 20 at the time of exposure 51 83.61 56 63.67 0.01 2.91 (1.30–6.52)
At  least one type of early skin lesion 104 75.91 3 25.00 0.001 9.45 (2.42–36.99)
Prevalence of pigmentation changes
RISK FACTOR N % N % P OR 95% CI
Acute dermatologic complication
Blistering 81 75.70 11 26.19 <0.001 8.78 (3.88–19.88)
Erythema 83 70.94 9 28.12 <0.001 6.24 (2.62–14.86)
Scaling  81 63.78 11 50.00 0.22 1.76 (0.71–4.38)
Pigmentation 82 63.56 10 50.00 0.24 1.74 (0.68–4.50)
Chemical exposure ≥ 1 time 26 52.00 66 66.67 0.08 0.54 (0.27–1.08)
Age  ≤ 20 at the time of exposure 41 67.21 51 57.95 0.25 1.49 (0.75–2.94)
At  least one type of early skin lesion 88 64.23 4 33.33 0.06 3.59 (1.03–12.54)
Table 6
Univariate logistic regression predicting xerosis and photosensitivity and in SM exposed survivors.
With risk factor Without risk factor
Prevalence of xerosis
RISK FACTOR N % N % P OR 95% CI
Acute dermatologic complication
Blistering 50 46.73 7 16.67 0.001 4.39 (1.79–10.74)
Erythema 51 43.59 6 18.75 0.01 3.35 (1.28–8.74)
Scaling 48 37.79 9 40.91 0.78 0.88 (0.35–2.21)
Pigmentation 49 38.00 8 40.00 0.86 0.92 (0.35–2.41)
Chemical exposure ≥ 1 time 16 32.00 41 41.41 0.26 0.67 (0.32–1.36)
Age  ≤ 20 at the time of exposure 21 34.43 36 40.91 0.42 0.76 (0.38–1.49)
At  least one type of early skin lesion 55 40.14 2 16.67 0.13 3.35 (0.71–15.90)
Prevalence of Photosensitivity
RISK FACTOR N % N % P OR 95% CI
Acute dermatologic complication
Blistering 19 17.76 3 7.14 0.10 2.81 (0.78–10.04)
Erythema 20 17.09 2 6.25 0.16 3.09 (0.68–14.00)
Scaling 21 16.53 1 4.54 0.20 4.16 (0.53–32.64)
Pigmentation 21 16.28 1 5.00 0.31 3.69 (0.47–29.12)
Chemical exposure ≥ 1 time 7 14.00 15 15.15 0.85 0.91 (0.35–2.40)
13 
1 
4
e
o
i
o
c
a
d
a
[
aAge  ≤ 20 at the time of exposure 9 14.75 
At  least one type of early skin lesion 21 15.33 
. Discussion
Our study showed that nearly all (91.94%) patients with SM
xposure-induced severe ophthalmological injuries had at least
ne of the acute phase cutaneous lesions, especially in the gen-
talia and great ﬂexures. According to the literature, the severity
f acute skin problems depends on the primary location (more
ommonly in warm and humid skin regions), dosage, and intensity
nd duration of exposure [20,26]. As the depth of dermatological
amage increases (e.g. causing blistering and necrotic wounds), the
rea and severity as well as the risk of late complications increase
3]. Factors such as exposure time, concentrations of mustard gas,
nd protective equipment (masks and specialized gas troops cloth14.77 0.99 1.00 (0.40–2.51)
8.33 0.69 1.99 (0.24–16.25)
uniform) are associated with the risk of acute lesions [19,3,7].
Patients with lower age, white race, and female gender experience a
severe form of acute manifestation. Some speciﬁc anatomical areas
such as scrotum, groin, armpits and genitalia with less evaporation
rate, secondary to warmth and humidity, and areas of the body
under tight clothing (e.g. military belt), secondary to the epider-
mis  tightening and ﬂaccidity are the most common sites of acute
involvement [3].
Excessive dry skin (xerosis), hyperpigmentation, burning sen-
sation, pruritis, hypopigmentation, and cherry angioma are the
most common non-speciﬁc skin lesions reported in the literature
[4,6,17]. The previously reported differences in the incidence and
prevalence of these lesions are affected by factors such as age,
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ocioeconomic status, geography, occupation, and genetics [8]. The
ifferences were also attributed to variations in patient sampling
nd assessment methods as well as the dose, duration, and exten-
ion of exposure [10]. Effects of exposure to different amount of SM
howed that concentrations of 100–400 mg/min/m3 causes slight
kin effects, while severe skin damage occurs with doses exceeding
50–1000 mg/min/m3 [3]
Our data showed that nearly all patients (92.62%) developed
ate cutaneous complications. This rate is much higher than that
eported by Emadi et al. (24.5%) [7]. We  found that patients hav-
ng at least one of the early skin lesions were at a higher risk of
eporting late skin lesions, especially pruritis, cherry angioma, and
urning. The occurrence and persistence of these skin lesions are
irectly dependent on the duration and the severity of exposure
3].
The high prevalence of developing severe acute and subsequent
hronic skin lesions in our study population compared to previous
tudies may  therefore be due to exposure to higher doses or longer
urations of SM exposure.
The most common chronic dermatologic complaint was  itching
nd was frequently associated with dryness and burning. Although,
ncreased TEWL (trans-epidermal water loss) and decreased sebum
roduction have been postulated in the pathogenesis of skin xero-
is and pruritis, the exact mechanism of pruritis is unknown [17].
hough pruritis worsens in dry weather and after physical activ-
ty, the role of psychological factors should not be ignored [3,10].
he psychological effects and sleep impairment due to pruritis can
everely affect quality of life [20]. Of note, a previous study reported
ry skin in the extremities [4], whereas our study observed dry skin
ost commonly in the mucous membranes.
We found that, in general, the prevalence of chronic skin com-
laints was associated most strongly with the early presence of
listering and erythema. These two acute lesions should therefore
e considered to be risk factors for developing chronic compli-
ations. Patients with early scaling lesions were at higher risk of
eporting pruritis and burning. Patients with pigmentation lesions
t the time of chemical exposure were more likely to have late
ruritis. Each of early cutaneous lesions (blister, scaling, pigmen-
ation, and erythema) was not signiﬁcantly related to developing
ate photosensitivity. In our study, we concluded that blistering (the
ost severe acute phase symptom), was a signiﬁcant predictor for
eveloping late phase pruritis.
Hyperpigmentation was also noted as a long-term complication
f SM exposure in this study. Possible mechanisms of hyperpigmen-
ation in the study population other than chronic inﬂammation,
ruritis, and excoriation include higher melanin content, activated
elanocytes, pigmentary incontinence due to hydropic changes in
pidermal basal layer, increase in tyrosinase activity due to deple-
ion of glutathione, increased melanogenesis and up-regulation of
elanocyte Stimulating Hormone (MSH) centrally from hypotha-
amus by interleukin-1 and tumor necrosis factor-. Interestingly,
ypopigmentation has also been reported in the SM-exposed pop-
lation via a proposed mechanism of melanocyte destruction
econdary to high concentration SM exposure. Given the reports of
 higher prevalence of vitiligo in SM-exposed patients, the mech-
nism of SM-mediated changes in pigmentation remains in doubt
10]. Future studies will help us better understand which mecha-
ism is more important in SM exposure.
In this study, we found that patients aged 20 years or less at
he time of chemical exposure were at higher risk of developing
herry angiomata and burning in comparison with older subjects
Tables 4 and 5). Prior studies have shown that the acute onset
f skin lesions in children and adolescents compared to adults is
horter and their lesions are more severe. This can be explained by
he increased skin sensitivity and greater vulnerability of this pop-orts 3 (2016) 679–684 683
ulation. Of note, lesions of the genitalia have been less frequently
reported in children than in adults [18].
We found that both the genitalia and great ﬂexure areas, fol-
lowed by the head & neck, extremities, and trunk were the most
commonly involved anatomical sites for skin lesions at the time of
SM exposure. Our results show that burning, pruritis, and pigmen-
tation changes were most commonly found in the great ﬂexures
and genitalia, whereas the trunk and extremities were the most
common sites for cherry angiomata. Photosensitivity was most
commonly observed on the head and neck.
The higher prevalence of cherry angiomata (ranged between
36 and 71.81%) with larger size and diffuse dissemination were
reported in the survivors. Although the exact mechanism is not
clear, direct SM-mediated DNA damage and release of angiogenic
cytokines has been proposed [10]. A few studies have reported
higher prevalences of disorders like cherry angioma, alopecia
areata, lichen planus, psoriasis, dermatitis seborrheic, vitiligo, and
discoid lupus erythematosus, tinea versicolor, and chronic urticaria
in subjects exposed to SM compared with the general population.
Complete alopecia was  reported in one patient. It seems, how-
ever, that there is not enough evidence yet to make deﬁnitive
claims about the increased prevalence of these conditions [5,17,8].
Interestingly, dry skin and associated itching appears to intensify
gradually over time in SM-exposed patients, while other skin com-
plications decrease [4]. A possible mechanism for the increase in
skin pathology in this population could be SM-mediated immune
dysregulation [3]. Both humoral and cellular immune functions
are impaired after SM exposure [3]. Changes in pro-inﬂammatory
markers and cytokines (such as IL-1 beta, IL-8, TNF-alpha, and
IL-6) have been observed in these patients [2] and may  ulti-
mately be useful as diagnostic biomarkers of cutaneous vesicant
injury.
Cellular, epidemiological, and toxicological evidences indicate a
causal association between SM exposure and increased incidence
of lung and skin cancers [11,12,13,9,25,16]. The association also
likely extends to leukemia. Accurate estimates of potential cancer
risk are limited due to the lack of exact and detailed information
about mustard gas exposure [24]. Given that the risks associated
with cancer cannot be measured accurately at mentioned period,
and usually requires longer time (about 35–45 years), exact and
regular examination − usually within three months- for evaluation
of potential cancers is strongly recommended [3].
Our analysis has some limitations. It was a descriptive study
in nature and therefore does not imply any causation. In addition,
since this study only examined SM-exposed individual with severe
ophthalmologic complications −a subgroup that may be indepen-
dently associated with greater doses of SM exposure- the results
cannot be generalized to all chemical victims. Further study with a
larger sample including all survivors is needed in order to conﬁrm
the relationships between early and late skin complications in all
sulfur mustard chemical victims. In addition, we  did not study the
relation of any type of pulmonary complications in this study. It is
recommended to assess the association of early and late skin man-
ifestations, to ﬁnd out the relation of the pulmonary complications
and its severity on late skin features.
5. Conclusion
Our study showed that the prevalence of pruritis, xerosis,
pigmentation changes, cherry angioma, and burning were more
associated with the presence of early blister and erythema (two
important risk factors) in SM exposed survivors with severe ocular
complications. The genitalia and great ﬂexure areas were the most
commonly involved anatomical sites for both early and late skin
lesions in these SM exposed survivors.
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